Monte Rosa Therapeutics, Inc.·4

Jan 4, 4:30 PM ET

Castle John C. 4

4 · Monte Rosa Therapeutics, Inc. · Filed Jan 4, 2023

Insider Transaction Report

Form 4
Period: 2023-01-03
Castle John C.
Chief Data Scientist
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-01-03+78,50078,500 total
    Exercise: $7.78Exp: 2033-01-02Common Stock (78,500 underlying)
Footnotes (1)
  • [F1]25% of this option shall vest and become exercisable on January 1, 2024, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION